Company News | Healrna Successfully Exhibits at the 2025 Tech-Powered Agriculture Conference & Suzhou Industrial Park Animal Biopharma Enterprise Salon

The 2025 Suzhou Technology-Empowered Agriculture Conference and Agricultural Frontier Achievements Exhibition & Matchmaking Event was grandly held on April 15, 2025 at Suzhou International Convention Hotel. The event was attended by distinguished guests including:

· The President of Chinese Academy of Agricultural Sciences

· Standing Committee Member of the Provincial Party Committee and Secretary of Suzhou Municipal Party Committee

· Vice Governor of Jiangsu Province

Healrna, as a leading enterprise in veterinary mRNA vaccine research and development, was honored to be invited to participate in the exhibition.

Concurrently, the inauguration ceremony of the Biotechnology Center of China Association for the Promotion of International Agricultural Cooperation and the Suzhou Industrial Park Animal Biopharmaceutical Enterprise Salon were successfully held on the afternoon of April 15 at NewOrigin Digital Bay. Professor Zhao Lixiang, Co-founder and CTO of Healrna, was invited to attend and share insights during the corporate exchange session.

The conference, under the theme "Technology Empowering Agriculture, Wisdom Shaping the Future", focused on new prospects for modern agricultural development. It brought together China's top research institutions, innovative enterprises and investment organizations to establish a trinity industrial ecosystem integrating "exhibition, matchmaking and transformation".

During the event, Healrna showcased its cutting-edge animal health solution - veterinary mRNA vaccines, and engaged in in-depth exchanges with numerous industry experts and fellow participants to jointly promote the healthy development of modern agriculture.

Since its establishment, Healrna has been dedicated to the research and development of mRNA vaccines. Over the years, the company has closely followed national policy directives, actively promoted the "innovation revolution" in mRNA vaccines, continuously broken through technical barriers in nucleic acid drugs, and committed itself to providing safer vaccines, more efficient delivery systems, and faster, more reliable epidemic prevention solutions for global public health.

The salon event featured three sequential segments: an inauguration ceremony for the new facility, a partnership signing ceremony, and an interactive salon sharing session. These activities brought together diverse stakeholders to foster enterprise collaboration, inject new vitality into the animal biopharmaceutical industry, strengthen its foundation, stimulate innovation momentum, and propel the sector toward higher-quality development.

During the event, Professor Zhao Lixiang shared insights on the company's latest R&D breakthroughs and expressed his anticipation for collaborative partnerships with industry peers. Together, they aim to address new challenges and opportunities in the biopharmaceutical field, contributing greater value to the advancement of animal and human health initiatives.

Moving forward, Healrna will continue to uphold its corporate spirit of "Innovation & Progress, Collaboration & Win-win" by optimizing innovative mRNA vaccine solutions for veterinary use. We are committed to contributing expertise to facilitate the implementation of Suzhou's Technology-Driven Agriculture Action Plan (2025-2027), while strengthening the comprehensive prevention and control technology system for major animal diseases.

#About Healrna #

Healrna is a high-tech enterprise engaged in the comprehensive provision of nucleic acid drug industrialization. The company's business spans the research and production of mRNA drugs, clinical trial design, data analysis, and other areas, with a focus on the development of mRNA technology-based infectious disease vaccines, cancer vaccines, cell therapies, protein replacements, and more.